RGEN Reports $194M Q1 Revenue, +15% YoY, $0.48 Adj EPS, FY26 Rev $803-833M, +9-13% Organic, $1.97-2.05 EPS
Repligen Corp · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $123.10
-18% in 7d after detection
Post-detection moves
1h
—
1d
+0.1%
3d
-1.7%
7d
-18%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS